Literature DB >> 10982242

Human stem cells express substance P gene and its receptor.

Y Li1, S D Douglas, W Ho.   

Abstract

We studied the expression of Substance P (SP) and its receptor in an established human stem cell line (TF-1) and primary stem cells derived from human placental cord blood (HPCB). Using reverse transcriptase polymerase chain reaction (RT-PCR) assay, SP mRNA is detected in both TF-1 cells and HPCB stem cells. Among the alpha, beta, gamma, and delta transcripts of the SP gene, only the beta, gamma, and delta transcripts are detectable in these cells. These RT-PCR-amplified transcripts are confirmed by Southern blot assay using a specific SP probe. Sequence analysis of the RT-PCR-amplified products transcribed from mRNA extracted from the HPCB stem cells also confirmed that these transcripts are identical to those found in human neurons. At the protein level, TF-1 cells produced endogenous SP as determined by an enzyme-linked immunosorbent assay (EIA). Capsaicin, a vanillyl fatty acid amide (ingredient of hot pepper), released SP from TF-1 cells. In addition, using RT nested-PCR analysis, we identified the presence of mRNA for neurokinin-1 receptor (NK-1R, the receptor for SP) in both TF-1 cells and HPCB stem cells, which was confirmed by Southern blot and DNA sequencing analysis. The demonstration that human stem cells express SP and its receptor support the notion that SP is biologically involved in the hematopoietic regulating network.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10982242     DOI: 10.1089/152581600419107

Source DB:  PubMed          Journal:  J Hematother Stem Cell Res        ISSN: 1525-8165


  9 in total

Review 1.  Neurokinin-1 receptor: functional significance in the immune system in reference to selected infections and inflammation.

Authors:  Steven D Douglas; Susan E Leeman
Journal:  Ann N Y Acad Sci       Date:  2010-11-22       Impact factor: 5.691

2.  Substance P up-regulates macrophage inflammatory protein-1beta expression in human T lymphocytes.

Authors:  Chang Jiang Guo; Jian Ping Lai; Hong Mei Luo; Steven D Douglas; Wen Zhe Ho
Journal:  J Neuroimmunol       Date:  2002-10       Impact factor: 3.478

3.  Substance P enhances HIV-1 infection in human fetal brain cell cultures expressing full-length neurokinin-1 receptor.

Authors:  Lynnae Schwartz; Sergei V Spitsin; John Meshki; Florin Tuluc; Steven D Douglas; John H Wolfe
Journal:  J Neurovirol       Date:  2013-06-14       Impact factor: 2.643

4.  Analog of somatostatin vapreotide exhibits biological effects in vitro via interaction with neurokinin-1 receptor.

Authors:  Sergei Spitsin; Florin Tuluc; John Meshki; Jian Ping Lai; Richard Tustin Iii; Steven D Douglas
Journal:  Neuroimmunomodulation       Date:  2013-07-05       Impact factor: 2.492

Review 5.  Neuropeptide substance P and the immune response.

Authors:  Alireza Mashaghi; Anna Marmalidou; Mohsen Tehrani; Peter M Grace; Charalabos Pothoulakis; Reza Dana
Journal:  Cell Mol Life Sci       Date:  2016-06-17       Impact factor: 9.261

Review 6.  The role of neurokinin-1 receptor in the microenvironment of inflammation and cancer.

Authors:  Marisa Rosso; Miguel Muñoz; Michael Berger
Journal:  ScientificWorldJournal       Date:  2012-04-01

7.  Bioinformatic Analysis and Cellular Assays Identify Substance P Influencing Th17/Treg Differentiation via the MyD88 Pathway as a Potential Contributor to the Progression of Asthma and Allergic Rhinitis.

Authors:  Yuemei Ma; Chang Liu; Guangpeng Xi; Yuanyuan Guan; Yao Tang; Jing Zhang; Yue Xu
Journal:  Dis Markers       Date:  2022-02-12       Impact factor: 3.434

8.  Neurokinin-1 receptor signalling impacts bone marrow repopulation efficiency.

Authors:  Alexandra Berger; Catherine Frelin; Divya K Shah; Patricia Benveniste; Robert Herrington; Norma P Gerard; Juan-Carlos Zúñiga-Pflücker; Norman N Iscove; Christopher J Paige
Journal:  PLoS One       Date:  2013-03-14       Impact factor: 3.240

9.  Substance P enhances the local activation of NK1R-expressing c-kit+ cardiac progenitor cells in right atrium of ischemia/reperfusion-injured heart.

Authors:  Yun-Mi Jeong; Xian Wu Cheng; Kyung Hye Lee; Sora Lee; Haneul Cho; Weon Kim
Journal:  BMC Mol Cell Biol       Date:  2020-06-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.